US30 event risk - a pivotal week of earnings ahead
US Q2 earnings this week – Citi, JP Morgan, Bank of America, Wells Fargo, UnitedHealth
This week we get the US big money centres out with earnings. The focus falls on asset quality, loan growth/contraction, net interest margins (NIM) and any commentary on the recent tightening of broad financial conditions.
When we look at the companies included in the US30, there are only two banks (of the 30 constituents) - Goldmans and JP Morgan. However, the US30 holds an incredibly high relationship with the XLF ETF (S&P financial sector ETF), with a 10-day correlation of 93%. With so many of the major financial institutions reporting, assuming this relationship holds up, the US30 should mirror the movement in the US banks.
Another important risk for US30 traders this week is how the market reacts to earnings from United Health (UNH - report on 13 October). UNH commands a massive 10% weight on the US30, arguably the biggest weight on the index. UNH is not a stock that CFD traders look at as closely as a say aTesla or Nvidia, given its more defensive price action. It’s one for the range traders, where buying into $460 and shorting into $520 has worked well over the past 12 months. However, given the weighting, US30 traders should be aware of the influence the stock can offer.
The market prices an implied move of 2.6% move on the day of UNHs reporting, which is in fitting with the average price change over the past 8 quarterly reporting periods. UNH has seen some large percentage moves over earnings and recall in the last earnings report the stock rallied 7.2% - so a sizeable rally/decline would influence the US30 given the weight.
While macro factors such as moves in bond yields, the USD and oil prices will influence the US30, one can see that earnings this week could also play a major role – time to buy the dip, or are we about to see a leg lower in the index?
This week we get the US big money centres out with earnings. The focus falls on asset quality, loan growth/contraction, net interest margins (NIM) and any commentary on the recent tightening of broad financial conditions.
When we look at the companies included in the US30, there are only two banks (of the 30 constituents) - Goldmans and JP Morgan. However, the US30 holds an incredibly high relationship with the XLF ETF (S&P financial sector ETF), with a 10-day correlation of 93%. With so many of the major financial institutions reporting, assuming this relationship holds up, the US30 should mirror the movement in the US banks.
Another important risk for US30 traders this week is how the market reacts to earnings from United Health (UNH - report on 13 October). UNH commands a massive 10% weight on the US30, arguably the biggest weight on the index. UNH is not a stock that CFD traders look at as closely as a say aTesla or Nvidia, given its more defensive price action. It’s one for the range traders, where buying into $460 and shorting into $520 has worked well over the past 12 months. However, given the weighting, US30 traders should be aware of the influence the stock can offer.
The market prices an implied move of 2.6% move on the day of UNHs reporting, which is in fitting with the average price change over the past 8 quarterly reporting periods. UNH has seen some large percentage moves over earnings and recall in the last earnings report the stock rallied 7.2% - so a sizeable rally/decline would influence the US30 given the weight.
While macro factors such as moves in bond yields, the USD and oil prices will influence the US30, one can see that earnings this week could also play a major role – time to buy the dip, or are we about to see a leg lower in the index?
Global risk Warning CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading in CFDs. You should consider whether you understand how CFD
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.